Partners in the PIONEER project have uploaded datasets from major studies, and are calling on others to do the same.
Lung Cancer Europe (LuCE) is holding a webinar on the role of the European Medicines Agency (EMA) and how patients and patient advocates can be involved in the drug approval process.
The webinar is intended for an audience of advocates, patients and caregivers. It will be given by Kate Morgan, Head of Policy and Access of Myeloma Patients Europe (MPE).
Over the last years, investigators at the US National Institute for Occupational Safety and Health(NIOSH) have published over 50 epidemiologic studies on workplace-related cancer.
The European Investment Bank (EIB) provides €40 million to ITM Isotopen Technologien München AG (ITM), a company dedicated to the development, production and global supply of innovative diagnostic and therapeutic radiopharmaceuticals for use in Precision Oncology. ITM will use the fresh funds for investments in research and development of a proprietary portfolio of Targeted Radionuclide Diagnostics and Therapies, addressing a range of cancers such as neuroendocrine tumours and bone metastases.
Europe’s Beating Cancer Plan is expected by the end of the year, and preparatory work and consultations are currently ongoing to shape the plan, set priorities and outline future action. This workshop looks into one of the key topics, modifiable risk factors and cancer prevention. Experts from all across the cancer spectrum will discuss with MEPs the state of play and main challenges, with a special angle on paediatric, digestive and HPV cancers.
By European Society of Cardiology
Today, on World Cancer Day, the European Commission is launching an EU-wide public consultation on Europe’s Beating Cancer Plan. The consultation will help shape the Plan, identify key areas, and explore future action.
World Cancer Day is this year being held for the 20th time. Fighting cancer is one of the EU’s health priorities. Read on to find out more about the measures in place.
Almost 1.2 million persons died from cancer in the European Union in 2016. Cancer was responsible for over one quarter (26%) of all deaths recorded in the EU.
On World Cancer Day, meet a few of the EIT Community entrepreneurs that are fighting cancer with their innovations.
By Lung Cancer Europe
Lung cancer is responsible for nearly 1 in 5 cancer related deaths in Europe, yet it remains a cancer that is underfunded and underrepresented. Previous research has demonstrated that many people impacted by lung cancer face disparities in access to diagnostics, treatment and care.
To mark World Cancer Day, LuCE has released its latest position paper which identifies disparities and challenges in access to lung cancer diagnostics and treatment across Europe. Data were collected through 34 healthcare professionals/researchers, 16 pharmaceutical companies and LuCE members (patient organizations).